Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials
13 janv. 2021 09h00 HE
|
Parexel International LLC
Companies partnering to reduce social determinants of health barriers to clinical trial enrollment BOSTON, DURHAM, N.C. and DALLAS, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Parexel and Signify Health...
Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
11 janv. 2021 06h00 HE
|
Parexel International LLC
Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...
Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer
04 janv. 2021 10h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
14 déc. 2020 12h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Named Best Contract Research Organization by Scrip
03 déc. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel und CTC North erhöhen gemeinsam Forschungskapazität für Durchführung früher klinischer Studien
23 nov. 2020 15h03 HE
|
Parexel International LLC
BOSTON und DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, ein führender Anbieter von Lösungen, die die Entwicklung und Bereitstellung innovativer Therapien – von der klinischen Phase bis...
Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials
23 nov. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
02 nov. 2020 09h30 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
20 oct. 2020 07h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
24 sept. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C. and ESCHBORN, Germany , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...